skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 807  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Database: Karger Open Access Journals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prevalence of and Risk Factors for Diabetic Retinopathy and Diabetic Macular Edema in Patients with Early- and Late-Onset Diabetes Mellitus
Material Type:
Article
Add to My Research

Prevalence of and Risk Factors for Diabetic Retinopathy and Diabetic Macular Edema in Patients with Early- and Late-Onset Diabetes Mellitus

Ophthalmic research, 2022-06, Vol.65 (3), p.293-299 [Peer Reviewed Journal]

The Author(s). Published by S. Karger AG, Basel ;The Author(s). Published by S. Karger AG, Basel. ;COPYRIGHT 2022 S. Karger AG ;Copyright © 2020 by S. Karger AG, Basel 2020 ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000508335 ;PMID: 32353847

Digital Resources/Online E-Resources

2
Retinal Blood Flow as a Predictor of Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Central Retinal Vein Occlusion
Material Type:
Article
Add to My Research

Retinal Blood Flow as a Predictor of Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Central Retinal Vein Occlusion

Ophthalmic research, 2021-12, Vol.64 (6), p.1013-1019 [Peer Reviewed Journal]

2021 The Author(s). Published by S. Karger AG, Basel ;2021 The Author(s). Published by S. Karger AG, Basel. ;COPYRIGHT 2021 S. Karger AG ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000519150 ;PMID: 34461615

Digital Resources/Online E-Resources

3
Real-World Outcomes after 36-Month Treatment with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema (BOREAL-DME)
Material Type:
Article
Add to My Research

Real-World Outcomes after 36-Month Treatment with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema (BOREAL-DME)

Ophthalmic research, 2021-08, Vol.64 (4), p.577-586 [Peer Reviewed Journal]

2020 S. Karger AG, Basel ;2020 S. Karger AG, Basel. ;COPYRIGHT 2021 S. Karger AG ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000511591 ;PMID: 32932257

Digital Resources/Online E-Resources

4
Optical Coherence Tomography Biomarkers: Vitreous Status Influence in Outcomes for Diabetic Macular Edema Therapy with 0.19-mg Fluocinolone Acetonide Implant
Material Type:
Article
Add to My Research

Optical Coherence Tomography Biomarkers: Vitreous Status Influence in Outcomes for Diabetic Macular Edema Therapy with 0.19-mg Fluocinolone Acetonide Implant

Ophthalmic research, 2021-08, Vol.64 (4), p.639-647 [Peer Reviewed Journal]

2021 The Author(s) Published by S. Karger AG, Basel ;2021 The Author(s) Published by S. Karger AG, Basel. ;COPYRIGHT 2021 S. Karger AG ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000515306 ;PMID: 33601389

Digital Resources/Online E-Resources

5
A Pathogenetic Classification of Diabetic Macular Edema
Material Type:
Article
Add to My Research

A Pathogenetic Classification of Diabetic Macular Edema

Ophthalmic research, 2018-01, Vol.60 (1), p.23-28 [Peer Reviewed Journal]

2018 S. Karger AG, Basel ;2018 S. Karger AG, Basel. ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000484350 ;PMID: 29642065

Digital Resources/Online E-Resources

6
Skin Eruptions in Acute Hemorrhagic Edema of Young Children: Systematic Review of the Literature
Material Type:
Article
Add to My Research

Skin Eruptions in Acute Hemorrhagic Edema of Young Children: Systematic Review of the Literature

Dermatology (Basel), 2022-05, Vol.238 (3), p.397-403 [Peer Reviewed Journal]

2021 The Author(s). Published by S. Karger AG, Basel ;2021 The Author(s). Published by S. Karger AG, Basel. ;Copyright © 2021 by S. Karger AG, Basel 2021 ;ISSN: 1018-8665 ;EISSN: 1421-9832 ;DOI: 10.1159/000519009 ;PMID: 34551420

Digital Resources/Online E-Resources

7
The Role of Steroids in the Management of Diabetic Macular Edema
Material Type:
Article
Add to My Research

The Role of Steroids in the Management of Diabetic Macular Edema

Ophthalmic research, 2019-01, Vol.62 (4), p.231-236 [Peer Reviewed Journal]

2019 S. Karger AG, Basel ;2019 S. Karger AG, Basel. ;ISSN: 0030-3747 ;ISBN: 3318066583 ;ISBN: 9783318066586 ;EISSN: 1423-0259 ;EISBN: 3318066591 ;EISBN: 9783318066593 ;DOI: 10.1159/000499540 ;PMID: 31048580

Digital Resources/Online E-Resources

8
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis
Material Type:
Article
Add to My Research

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis

Ophthalmologica (Basel), 2024-02, Vol.247 (1), p.19-29 [Peer Reviewed Journal]

2023 The Author(s). Published by S. Karger AG, Basel ;2023 The Author(s). Published by S. Karger AG, Basel. ;ISSN: 0030-3755 ;EISSN: 1423-0267 ;DOI: 10.1159/000533443 ;PMID: 37579730

Digital Resources/Online E-Resources

9
Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment
Material Type:
Article
Add to My Research

Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment

Ophthalmic research, 2023-01, Vol.66 (1), p.39-47 [Peer Reviewed Journal]

2022 The Author(s). Published by S. Karger AG, Basel ;2022 The Author(s). Published by S. Karger AG, Basel. ;COPYRIGHT 2023 S. Karger AG ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000525412 ;PMID: 35697006

Digital Resources/Online E-Resources

10
Study of Nonperfusion Area Changes after Ranibizumab Intravitreal Injection for Diabetic Macular Edema by Means of Widefield OCT Angiography
Material Type:
Article
Add to My Research

Study of Nonperfusion Area Changes after Ranibizumab Intravitreal Injection for Diabetic Macular Edema by Means of Widefield OCT Angiography

Ophthalmic research, 2023-01, Vol.66 (1), p.8-13 [Peer Reviewed Journal]

2022 The Author(s). Published by S. Karger AG, Basel ;2022 The Author(s). Published by S. Karger AG, Basel. ;COPYRIGHT 2023 S. Karger AG ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000523749 ;PMID: 35313317

Digital Resources/Online E-Resources

11
HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model
Material Type:
Article
Add to My Research

HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model

Cellular physiology and biochemistry, 2018-01, Vol.46 (6), p.2532-2542 [Peer Reviewed Journal]

2018 The Author(s). Published by S. Karger AG, Basel ;2018 The Author(s). Published by S. Karger AG, Basel. ;ISSN: 1015-8987 ;EISSN: 1421-9778 ;DOI: 10.1159/000489659 ;PMID: 29742510

Full text available

12
α-Lipoic Acid Promotes Neurological Recovery After Ischemic Stroke by Activating the Nrf2/HO-1 Pathway to Attenuate Oxidative Damage
Material Type:
Article
Add to My Research

α-Lipoic Acid Promotes Neurological Recovery After Ischemic Stroke by Activating the Nrf2/HO-1 Pathway to Attenuate Oxidative Damage

Cellular physiology and biochemistry, 2017-01, Vol.43 (3), p.1273-1287 [Peer Reviewed Journal]

2017 The Author(s). Published by S. Karger AG, Basel ;2017 The Author(s). Published by S. Karger AG, Basel. ;ISSN: 1015-8987 ;EISSN: 1421-9778 ;DOI: 10.1159/000481840 ;PMID: 28992629

Full text available

13
Intravitreal Dexamethasone Implant Has Better Retinal Perfusion than Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion: A Five-Year Real-World Study
Material Type:
Article
Add to My Research

Intravitreal Dexamethasone Implant Has Better Retinal Perfusion than Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion: A Five-Year Real-World Study

Ophthalmic research, 2023-01, Vol.66 (1), p.247-258 [Peer Reviewed Journal]

2022 The Author(s). Published by S. Karger AG, Basel ;2022 The Author(s). Published by S. Karger AG, Basel. ;COPYRIGHT 2023 S. Karger AG ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000527447 ;PMID: 36215955

Digital Resources/Online E-Resources

14
New Insights in Resistant Diabetic Macular Edema
Material Type:
Article
Add to My Research

New Insights in Resistant Diabetic Macular Edema

Ophthalmologica (Basel), 2021, Vol.244 (6), p.485-494 [Peer Reviewed Journal]

2021 The Author(s) Published by S. Karger AG, Basel ;2021 The Author(s) Published by S. Karger AG, Basel. ;ISSN: 0030-3755 ;EISSN: 1423-0267 ;DOI: 10.1159/000516614 ;PMID: 34023834

Digital Resources/Online E-Resources

15
Effects of Intravitreal Ranibizumab Injection to Treat Macular Edema due to Central Retinal Vein Occlusion on Choroidal Findings and Functional-Morphological Parameters
Material Type:
Article
Add to My Research

Effects of Intravitreal Ranibizumab Injection to Treat Macular Edema due to Central Retinal Vein Occlusion on Choroidal Findings and Functional-Morphological Parameters

Ophthalmic research, 2023-01, Vol.66 (1), p.1063-1070 [Peer Reviewed Journal]

2023 The Author(s). Published by S. Karger AG, Basel ;2023 The Author(s). Published by S. Karger AG, Basel. ;2023 The Author(s).Published by S. Karger AG, Basel 2023 ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000531498 ;PMID: 37331343

Digital Resources/Online E-Resources

16
Changes in Ganglion Cell Layer Thickness after Treatment with the 0.2 µg/day Fluocinolone Acetonide Implant in Vitrectomized and Nonvitrectomized Eyes with Diabetic Macular Edema
Material Type:
Article
Add to My Research

Changes in Ganglion Cell Layer Thickness after Treatment with the 0.2 µg/day Fluocinolone Acetonide Implant in Vitrectomized and Nonvitrectomized Eyes with Diabetic Macular Edema

Ophthalmic research, 2022, Vol.65 (3), p.310-320 [Peer Reviewed Journal]

2022 The Author(s). Published by S. Karger AG, Basel ;2022 The Author(s). Published by S. Karger AG, Basel. ;COPYRIGHT 2022 S. Karger AG ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000520411 ;PMID: 35086095

Digital Resources/Online E-Resources

17
Optical Coherence Tomography Biomarkers Predicting Visual Acuity Change after Intravitreal Bevacizumab Injections for Macular Edema Secondary to Branch Retinal Vein Occlusion
Material Type:
Article
Add to My Research

Optical Coherence Tomography Biomarkers Predicting Visual Acuity Change after Intravitreal Bevacizumab Injections for Macular Edema Secondary to Branch Retinal Vein Occlusion

Ophthalmologica (Basel), 2022-01, Vol.245 (1), p.19-24 [Peer Reviewed Journal]

2021 The Author(s). Published by S. Karger AG, Basel ;2021 The Author(s). Published by S. Karger AG, Basel. ;ISSN: 0030-3755 ;EISSN: 1423-0267 ;DOI: 10.1159/000519373 ;PMID: 34510041

Digital Resources/Online E-Resources

18
The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema
Material Type:
Article
Add to My Research

The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema

Ophthalmic research, 2020-01, Vol.63 (2), p.114-121 [Peer Reviewed Journal]

2019 The Author(s)Published by S. Karger AG, Basel ;2019 The Author(s)Published by S. Karger AG, Basel. ;Copyright © 2019 by S. Karger AG, Basel 2019 ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000503036 ;PMID: 31801148

Digital Resources/Online E-Resources

19
Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers
Material Type:
Article
Add to My Research

Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers

Ophthalmic research, 2024, Vol.67 (1), p.96-106 [Peer Reviewed Journal]

2024 The Author(s). Published by S. Karger AG, Basel. ;ISSN: 0030-3747 ;EISSN: 1423-0259 ;DOI: 10.1159/000535199 ;PMID: 38211574

Digital Resources/Online E-Resources

20
Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis
Material Type:
Article
Add to My Research

Anti-Vascular Endothelial Growth Factor Treatment Compared with Steroid Treatment for Retinal Vein Occlusion: A Meta-Analysis

Ophthalmologica (Basel), 2023-01, Vol.245 (6), p.500-515 [Peer Reviewed Journal]

2022 The Author(s). Published by S. Karger AG, Basel ;2022 The Author(s). Published by S. Karger AG, Basel. ;ISSN: 0030-3755 ;EISSN: 1423-0267 ;DOI: 10.1159/000527626 ;PMID: 36288721

Digital Resources/Online E-Resources

Results 1 - 20 of 807  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1984  (12)
  2. 1984 To 1994  (18)
  3. 1995 To 2003  (24)
  4. 2004 To 2013  (73)
  5. After 2013  (682)
  6. More options open sub menu

Language 

  1. Japanese  (53)
  2. Portuguese  (14)
  3. Norwegian  (1)
  4. More options open sub menu

Searching Remote Databases, Please Wait